Protagonist Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:PTGX) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -72.48 M-107.86 M-108.14 M-70.24 M184.15 M57.67 M -116.64 M Cash from investing activities -90.97 M-15.86 M91.47 M-39.26 M-299.48 M-49.33 M 135.96 M Cash from financing activities 247.63 M129.92 M18.84 M170.48 M25.85 M22.86 M 34.8 M Free cash flow -72.48 M-107.86 M-108.14 M-70.24 M184.15 M56.08 M -117.89 M

News

J&J Stock Gains Nearly 12% Year to Date: Buy, Sell or Hold Now?

J&J Mastered Cancer Biotech Deals on the Cheap. Can It Stay on the Cutting Edge?

J&J & Pfizer Face Patent Risks: Which Stock Looks Better Positioned?

J&J's Pipeline Progress & New Drugs Promise Stronger Long-Term Growth

Tremfya, Icotyde Lead J&J's Post-Stelara Immunology Strategy

How to Play J&J Stock Post a Beat-and-Raise Performance in Q1

Johnson & Johnson: Why I See Downside Ahead (NYSE:JNJ)

J&J raises guidance for 2026 on strong start to the year

Growth vs. Stability: Lilly and J&J's 2026 Investment Face-Off

Can New Drugs Drive J&J's Innovative Medicine Despite Stelara LOE?

J&J's Pipeline Surge Sets Up Stronger Growth From New Drugs in 2026

J&J Stock Trading Above 200- & 50-Day SMA for 8 Months: Time to Buy?